Good Distribution Practice and Supply Chain Risk Evaluation
|
|
- Dennis Moses Fowler
- 6 years ago
- Views:
Transcription
1 Good Distribution Practice and Supply Chain Risk Evaluation
2 Who we are - Exelsius An international consultancy established in 2007 bringing cross-sector expertise and skills into a range of services designed to support the implementation of Good Distribution Practice in the Life Sciences and Pharmaceutical Logistics Sector
3
4 Successfully Introducing Biosimilars to Market Choose Wisely Choosing the right market is the first step. Consider the most prevalent and costly diseases to treat with the biggest impact Access Markets Focus on innovative market access and financing approaches Distribute Safely Create effective transportations solutions in partnership with proven suppliers. Look for long-term distribution strategies to ensure clients are supplied
5 Safe Distribution is Your Responsibility CSafe Incheon Workshop Safe Distribution is Your responsibility Distribute Safely Create effective transportations solutions in partnership with proven suppliers. Look for long-term distribution strategies to ensure clients are supplied Good Distribution Practice (GDP): that part of quality assurance which ensures products are consistently stored, handled and transported under suitable conditions as required by the marketing authorization or product specification
6 Good Distribution Practice Guidance Global Sources of GDP Guidance EU343/01 Effective since 2014 USP 1079 (and upcoming USP1083) IATA TCR for air cargo WHO 957
7 European Economic Commission (EEC) - DIRECTIVE 94/C63/03 Guidelines on GDP for Human Use (Wholesalers) European Economic Commission - DIRECTIVE 2001/83/EC Community Code Medicinal Products for Human Use U.S. Army Packing Protocols for 2-8C TSMP There are a number of guidance documents Australia Therapeutic Goods Administration Code of Good Warehousing Practice US FDA 21 CFR & Warehousing Procedures & Distribution Procedures Italy Ministero Della Sanita Guidelines on GDP for Human Use World Health Organization TRS 937, Annex 5 GDP Irish Medicines Board Guide to Control and Monitoring of Storage & Transport PDA Technical Report No.46 for Medicinal Products Last Mile GDP to the End User International Conference on Harmonization (ICH) QA1 (R2) or CPMP/ICH/2736/99 Stability Testing of New Drug Substances and Products Brazil Australia Vaccine Storage USP General Chapter <1079> Good Storage & Shipping Practices Canada Health Canada GUI 0069 Guidelines for Temperature Control of Drug Product during Storage & Transport Singapore & ASEAN Member Countries Health Science Authority Guidance Notes on Good Distribution Practices International Air Transport Association (IATA) PCR Chapter 17 - Air Transport Logistics for Time & Temperature- Sensitive Healthcare Products India Israel CPMP/GWP/609/96/Rev2 EMEA Guideline on the Declaration of Storage Conditions MHRA Chapters 6 & 7 EU Guidance on Wholesale Distr. Practices PDA Technical Report No. 39 Guidance for Temperature Controlled Medicinal Products Romania Czech Republic Egypt World Health Organization Model requirements for the storage and transport of time and temperature sensitive pharmaceutical products Malaysia Argentina Saudi Arabia PIC/s, GDP IATA EEC USP MHRA EU API
8 There is a clear message from GDP regulators Thermal protection of temperature-sensitive medicines is essential throughout the distribution process Manufacturers and suppliers must pre-evaluate their transportation routes and audit their supply chain partners before use Contracted supply chain activities require a quality/service level agreement to be in place Quality Management Systems and preventive measures are to protect product quality in the total supply chain
9 What you cannot do with GDP Regulations You have a duty of compliance!
10 Overall GDP Responsibility rests with the Manufacturer EU Guidance Manufacturers Wholesalers Brokers Logistics Service providers Distributors, Equipment Responsibilities Duties
11 GDP is all about Risk! GDP is about Risk - a Calculation of Hazard and Probability
12 Risk Identification Knowing Key Risk Points means knowing where to Act Manufacturers & Shippers Product/Package pre-conditioning Product Loading Origin Forwarders & Trucking Co s. Solution Providers Ground Transportation Airport Ground Handlers Warehousing Origin-Destination Air Carrier Tarmac/Apron Areas Aircraft Cargo Hold Airport Ground Handlers Destination Forwarders & Trucking Co s Product Unloading Distributors & Consignees Ground Transportation Final Distribution 2016 EXELSIUS CONSULTANCY
13 As Globalized Production Grows, so Does Risk Longer supply chains Seasonal temperature variations More use of indirect logistics Infrastructure weaknesses Transportation has become an integral and tightly controlled part of the manufacturing process
14 A Totally Controlled Environment does not exist! Manufacturing, storage and packing Trucking Distribution handling & loading Storage, handling & loading Trucking Controlled Processes & Environment Uncontrolled Processes & Environment Controlled Processes & Environment
15 Question what is the likely temperature inside a Regular air cargo container exposed to +20ºC sunlight for 2 hours on an airport ramp? 1. 26C / 78.8F 2. 36C / 96.8F 3. 46C / 114.8F 4. 56C / 132.8F 5. 66C / 150.8F 6. 76C / 168.8F 7. 86C / 186.8F 8. 96C / 204.8F 76C / 168.8F
16 Protecting Your Product Protection during Transport is a GDP Requirement Active Containers Passive Packaging But so too is evaluating your supply chain partners
17 Transportation doesn t happen in a laboratory and routes should be Qualified to assess risk Design Qualification (DQ) Operational Qualification (OQ) Performance Qualification (PQ) Transport Qualification
18 Outsourced Activities through Suppliers Present A Risk CSafe Incheon Workshop The word Risk is repeated: 27 times in the 10 chapters of the new EU GDP Guidelines 19 times in the WHO 957 document
19 Assessing Risk and Supply Chain Partners GDP Risk Assessment Tool Developed by Exelsius for CSafe Customers
20 The Tool Allows a Risk Evaluation of Every Step Master Table
21 First Stage The first stage identifies individual process steps, timings and the process owner, allowing an endto-end analysis to be created.
22 Next stage identifies key compliance requirements of suppliers
23 Risk Assessment Third stage assess the risk levels of each process step, against a risk level calculation
24 Outsourced Activities are a key area of Risk Key Elements Contract giver is responsible for activities contracted OUT through: Audits GDP risk assessments Contract acceptor accountable for activities IN and must have adequate premises, expertise, procedures etc. to carry out the work Extends to any third party supplier/vendor Must have pre-assessed a supplier before any activity
25 The importance of Written Agreements Any activity covered by GDP that is outsourced should be correctly defined, agreed and controlled in order to avoid misunderstandings which could affect the integrity of the product. There must be a written Contract between the Contract Giver and the Contract Acceptor which clearly establishes the duties of each party EU GDP Guidelines 2013/C 343/01
26 Quality Agreements Three Important W s Why do you need a Quality Agreement? When is a Quality Agreement needed? Who should prepare the Quality Agreement?
27 Service Level/Quality Agreements A contract between a (logistics) service provider and its client(s). Specifies what agreed level of service will be provided, how performance may be measured and any delivery specifications. Deals with how exceptions and changes are managed. When used effectively, can be a significant communication tool that allows for performance improvements and also prevents conflicts.
28 Making SLA s work with your customers/suppliers 7.Impleme nt & Manage 1.Review needs and capabilities The value of an SLA can come from the initial discussion and mutual understanding it brings. 6.Get Ready 2.Agree the agreement Create regular day-to-day communication lines between stakeholders and use them. 5.Get buyin 3.Agree the Ground Rules Give feedback. 4.Develop a draft SLA Be realistic about expectations; measure progress & share it.
29 Service Characteristics and Management of Agreements Service Responsibilities Terms of business/trading conditions Transportation service standards Contact list and contingency plans Management Management Quality Management Systems Quality audits processes Performance management (e.g. KPI s) Revision methods
30 Make Performance Measurement Meaningful Align key performance measurements of your vendor(s) to the specific requirements of your product(s) and that of the prevailing regulatory requirements, e.g. : Temperature Management performance Pick-up and delivery performance Equipment, premises and procedures Measure the few, not the many Beware of quality fade Incorporate audits and assessment schedules into the service level agreement
31 Safe Distribution is Your Responsibility CSafe Incheon Workshop Supply Chain Risk Evaluation Distribute Safely Create effective transportations solutions in partnership with proven suppliers. Look for long-term distribution strategies to ensure clients are supplied Identify Stages Assess Compliance Calculate Risk Mitigate Risk
32 IQPC London 30 January 2016
Healthy solutions for the healthcare industry.
Healthy solutions for the healthcare industry. Vertical Market Healthcare Solutions Photo: thinkstock We take care of the products that take care of people. The reliable delivery of healthcare products
More informationApplying a Knowledge-Based Approach to Pharmaceutical Supply Chain Temperature Control Management
May 1-3, 2012 Javits Center New York, NY Applying a Knowledge-Based Approach to Pharmaceutical Supply Chain Control Management Arminda O. Montero Program Manager, Distribution QA Global Pharmaceutical
More informationA Global Review of Good. Brought to you by Cold Chain IQ
A Global Review of Good Distribution Practices Brought to you by Cold Chain IQ Contents v Introduction 3 v GDP Goes International 4 v Updates 5 v Worldwide Regulations 10 v More Regulations 12 v A One
More informationCold Chain Committee Guidance for shippers, transport service providers and subcontractors
Guidance for shippers, transport service providers and subcontractors involved in the distribution of pharmaceutical products registered for storage between 2 and 8 Celsius Guidance for Shippers 1 of 7
More informationQS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain
QS, GDP (+GMP?) Maintaining the Integrity of The Supply Chain Presented by: Karen Ginsbury For IFF 01 March, 2017 Pharma Supply Chain Manufacturer Wholesaler Raw Material Supply Production Transport Warehouse
More informationLogistic Provider Qualification: prerequisites and SLA
Logistic Provider Qualification: prerequisites and SLA Summary of the Content Benchmarking comparable providers and services to cope with product and market requirements Pre-qualification Activities Operational
More informationEuropean Union (EU) Regulatory Trends in GMP. Clive Brading Tianjin, China September 23, 2009
European Union (EU) Regulatory Trends in GMP Clive Brading Tianjin, China September 23, 2009 -2- Presentation Topics EU Background Inspections outside the EU EMEA Inspection Outcomes Dedicated Facilities
More informationCSafe Utilization in a Quality Management System. Scott Garchar Manager - Global Business Development FedEx Custom Critical
CSafe Utilization in a Quality Management System Scott Garchar Manager - Global Business Development FedEx Custom Critical Agenda CSafe Relationship History Current State Review Quality Management System
More informationCold Chain Custody Quality Aspects. Nigel Bleakley Associate Director Validation 16 Feb, 2015
Cold Chain Custody Quality Aspects Nigel Bleakley Associate Director Validation 16 Feb, 2015 Agenda Introduction to Adelaide site South Australia Cold Chain Custody Quality Aspects Case study frozen shipments
More informationGMP Track 1 Day 2 Session 1 Vendor Assurance
GMP Track 1 Day 2 Session 1 Vendor Assurance 11 August 2015 150403_POUT This session Three presentations Chapter 6 and 7 - Trevor Schoerie Quality Control Out sourced Activities Draft - FDA Quality Metrics
More informationFrancisco Rizzuto IATA Cargo Manager for Western Europe Specialized in Temperature Controlled Shipments for Pharmaceuticals
Francisco Rizzuto IATA Cargo Manager for Western Europe Specialized in Temperature Controlled Shipments for Pharmaceuticals Pharma Process Forum BCN, October 28 th 205 Q3 205 2 The International Air Cargo
More informationSupplier Qualification and Regulatory Compliance in International Biopharm Logistics. November 19 th, Copenhagen, 2015
Supplier Qualification and Regulatory Compliance in International Biopharm Logistics November 19 th, Copenhagen, 2015 Pharmaceutical Quality Management Partner Selection and Qualification Outsourcing and
More informationQuality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals
Quality Agreements with CMO s Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals FDA Guidance Contract Manufacturing Arrangements for Drugs: Quality
More informationOursourcing and Supplier Qualification from the perspective of the pharmaceutical Industry
Oursourcing and Supplier Qualification from the perspective of the pharmaceutical Industry 1 Presentation Outline Pharmaceutical Quality Management Partner Selection and Qualification Shipping Qualification
More informationThe Quality Agreement evolved to fill these gaps and address these challenges.
A Model for Pharmaceutical Supply Chain Quality Agreements Rafik H. Bishara, Steve Jacobs, and Dan Bell The Evolution of the Quality Agreement Over a decade ago, the way business was conducted between
More informationUNICEF Quality Assurance in the procurement of medicines
UNICEF Quality Assurance in the procurement of medicines Peter S. Jakobsen 30 October 2006 Quality Assurance Centre SUPPLY DIVISION Today s presentation addresses 3 questions: How is UNICEF involved in
More informationCHINA. Australia - China Life Science Summit. . Bio & Pharma Logistics
CHINA. Bio & Pharma Logistics Andrew McDonald Operations Director, Asia Pacific Melbourne, Australia, 27th March 2013 Australia - China Life Science Summit Responsibilities Who takes responsibility on
More informationIATA e-freight. An IATA Simplifying the Business (StB) Programme. A Key pillar of the IATA Cargo Agenda
IATA e-freight An IATA Simplifying the Business (StB) Programme A Key pillar of the IATA Cargo Agenda What is e-freight Process and Challenges 2 IATA e-freight: e What is it? e-freight is Paper-Free: Taking
More informationImpacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario
Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Innovacion en Packaging Primario 1 Contents Company Highlight What s Changing in Pharma Pharma Trends Harmonisation New Requirements
More informationCase Study: Implementing the CEIV Program and Lessons Learned. Nathan De Valck Cargo account manager Brussels Airport Company
Case Study: Implementing the CEIV Program and Lessons Learned Nathan De Valck Cargo account manager Brussels Airport Company 2 June 2015 Pharma Context Pharma clusters within reach of BRU Source: the European
More informationMHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents
MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Complex Business Models - Outsourced Activities Presented by: Jacqueline Masayi, GDP Inspector Background Increased complexities of the
More informationPractical and Value Generating Approach to IATA Chapter 17 7 th Edition of the Perishable Cargo Regulations -- David Y. Bang
Practical and Value Generating Approach to IATA Chapter 17 7 th Edition of the Perishable Cargo Regulations -- David Y. Bang With much anticipation and efforts by those who work daily with perishable cargo,
More informationCHALLENGES OF GLOBAL CLINICAL TRIAL SUPPLY SOURCING SOME SPECIFICS FOR EMERGING MARKETS
Clinical Trial Supply 28 th 29 th October 2014 Princeton, NJ - USA CHALLENGES OF GLOBAL CLINICAL TRIAL SUPPLY SOURCING SOME SPECIFICS FOR EMERGING MARKETS 1 Agenda The challenges associated with various
More informationBrussels Airport Gateway for the time and temperature controlled supply chain
Brussels Airport Gateway for the time and temperature controlled supply chain Nathan De Valck Cargo Account manager Central location in Europe Brussels, a top European Logistics Hub, in the political,
More informationOverview of Regulatory Requirements for API and Formulations
Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed
More informationGMP GUIDELINES. GMP Guides from Industry Organisations. FDA cgmp WHO GMP. cgmp Guide Drugs 21 CFR 210 GAMP. ISPE Technical Guides
FDA cgmp cgmp Guide Drugs 21 CFR 210 cgmp Guide Drugs 21 CFR 211 cgmp Guide Medical Device 21 CFR 808, 812, 820 cgmp Guide Biologics 21 CFR 600, 606, 610 Guideline List Human Drugs Guideline List Biologics
More informationOutsourcing - managing risks and opportunities over which you now have less control
Outsourcing - managing risks and opportunities over which you now have less control Kevin O Donnell, PhD PDA Meeting, Dublin 22 nd November 2018 Slide 2 Typical Examples The key GMP Requirements & Guidance
More informationGAMP5 Validation for Dynamics 365
GAMP5 Validation for Dynamics 365 Prepared by: Michael Webster, Business Development Director, RSM US LLP michael.webster@rsmus.com, +1 617 241 1544 Dynamics 365 is an ideal enterprise resource planning
More informationImplementation of EU Falsified Medicines Directive
Implementation of EU Falsified Medicines Directive Gerald W Heddell Director, Inspection, Enforcement & Standards Division 26th Annual EuroMeeting 25-27 March 2014 ACV, Vienna Austria Disclaimer The views
More informationHow are forwarders addressing the demands of shippers for cost effective air distribution of pharmaceuticals?
How are forwarders addressing the demands of shippers for cost effective air distribution of pharmaceuticals? An introduction to Pharmafreight 1 2 3 4 5 6 7 Established back in 2001 Part of Mach 2 Group
More informationGMP Compliance. George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd
GMP Compliance George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd June 2017 Overview GMP Definition and Regulation Our Philosophy and Strategy for Compliance Project Lifecycle Deliverables Master
More informationRevision of Chapter 7 Contract Manufacture and Analysis
Revision of Chapter 7 Contract Manufacture and Analysis GMP & Market Compliance Information Day, 14-10-2010 Catherine Neary Inspector Date Insert on Master Slide Slide 1 Overview Purpose of revision to
More informationUNICEF Quality Assurance in the procurement of medicines
UNICEF Quality Assurance in the procurement of medicines Peter S. Jakobsen October 2008 Quality Assurance Centre SUPPLY DIVISION 2 Today s presentation addresses 3 questions: How do UNICEF manage quality
More informationChicago, The Gwen Hotel, 21 September HPCLC; Chicago, IL, USA; 21 September 2016
Chicago, The Gwen Hotel, 2 September 206 2 September 206 Background: The impact of mode shift on pharmaceutical logistics The pharmaceutical industry has relied heavily on the airline industry for its
More informationImpact of EU GMPs on Australian GMP. Trevor Schoerie PharmOut
Impact of EU GMPs on Australian GMP Trevor Schoerie PharmOut Part I Basic Requirements for Medicinal Products Current TGA Version, 7 years out of date TGA are actively and publically talking about PE009-0813
More informationQUALITY ASSURANCE. Pharma Quality Agreements: What Are They, and Why They Matter For Your Study ABSTRACT
WHITE PAPER PRESENTED BY PREMIER RESEARCH Pharma Quality Agreements: What Are They, and Why They Matter For Your Study ABSTRACT Quality Agreements are an effective bridge to a successful future for companies
More informationYour Partner Of Choice For Global Pharma Compliance. Corporate Presentation
Your Partner Of Choice For Global Pharma Compliance. Corporate Presentation Vision We aspire to be a partner of choice for global compliance & project management across the pharmaceutical value chain,
More informationRegulatory Update. Paul Sexton. QP Forum
Regulatory Update Paul Sexton QP Forum 16 th April, 2015 Content Updates on GMP Guidance Updates on EU Legislation Draft Ph Eur monograph on WFI including RO 2 Chapter 5 - Production Paragraphs 27 to 30
More informationValidation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October :30 12:00
Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October 2014 08:30 12:00 Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel
More informationEnabling Improvement through the Product Lifecycle: Change Management within a PQS
Enabling Improvement through the Product Lifecycle: Change Management within a PQS Denise DiGiulio, Senior Advisor OPQ Office of Process and Facilities PDA Chapter Meeting Melbourne, Australia April 3,
More informationPharma Market Growth and The Cost of Doing Business
Pharma Market Growth and The Cost of Doing Business May X, 2010 Agenda Pharma Market Overview Pharma Market Trends Cold Chain Complexities Freight Overview Pharma Costs and the Cost of Loss and Excursions
More informationDesigning your supply chain as accurately as possible based on thorough product testing
Designing your supply chain as accurately as possible based on thorough product testing Virginie ROUX Sanofi R&D Clinical Supplies Scientific Core Platform Agenda I. Our organization II. Adaptability to
More informationWholesaling & Distribution & the GMPs
Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the
More informationWholesaling & Distribution & the GMPs
Wholesaling & Distribution & the GMPs Presented by Bryan Wright 11 th July 2016 Overview Wholesaling & distribution of Medicines (FPs) in the EU New EU GDP Guidelines Expectations How complicated can the
More informationRegulations in Pharmaceutical Laboratories
Regulations in Pharmaceutical Laboratories February 2004 Ludwig Huber Compliance Fellow for Life Sciences and Chemical Analysis Chairperson: Rob Sample Regulations and Quality Standards Developed by Industries
More informationPharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES
Pharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES DB Schenker Healthcare Conference Europe April 17-18 th 2012 J. BERLO Industrial Pharmacist/Clin. Biol.
More informationOverview SFLGDP1. Develop, implement and maintain a quality system to control the distribution of medicinal products
Overview This standard is about developing, implementing and maintaining a quality system to control the. You will be responsible for developing the quality system and confirming colleagues understand
More informationTaking a Leap Toward Global Supply Chain Efficiency - Part II
Taking a Leap Toward Global Supply Chain Efficiency - Part II 2 Supply Chain Brochure - Part II INTRODUCTION Pharmaceutical manufacturers face a number of challenges in the production and delivery of medicinal
More informationReferences Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.
References Concept Principle a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which
More informationExperience with Serialization Implementation as one powerful measure to protect our patients. Françoise Hirth
Experience with Serialization Implementation as one powerful measure to protect our patients Françoise Hirth Objectives 1 2 3 Supply Chain integrity & product security A worldwide concern Pharma Industry
More informationChallenges and Opportunities in Pharma: Perspective for an Emerging Middle East April 24th, 2015
Challenges and Opportunities in Pharma: Perspective for an Emerging Middle East 2020 April 24th, 2015 Content Pharma Market Landscape Global Pharma Market Market Categories Middle East Markets Major Challenges
More informationQuality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology
PharmaTutor PRINT ISSN: 294-6679 E-ISSN: 247-788 2 Quality Risk Management (QRM) of active pharmaceutical ingredients during transportation by using FMEA tools and methodology Upendra Kumar Singh*, Sammer
More informationAgenda. What is considered as perishable? Food vs. Pharma: similarities and differences. Transportation & Infrastructure Requirements
Mr. Ingo Ocklenburg Mr. Michael Vorwerk Mr. Patrick Güth Agenda What is considered as perishable? Food vs. Pharma: similarities and differences Packaging and Handling Regulatory Requirements Transportation
More informationLife Sciences Courseware. Knowledge. Performance. Impact.
Life Sciences Courseware Knowledge. Performance. Impact. Now there s a flexible, affordable way to achieve your compliance training goals. In the Life Sciences industry, it s vital that your people are
More informationGood Manufacturing Practices Purpose and Principles of GMP. Tony Gould
Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines
More informationHealth Authority Inspection Management. GMP Inspection practices L. Mansolelli, Group Compliance & Auditing June 2012
Health Authority Inspection Management GMP Inspection practices L. Mansolelli, Group Compliance & Auditing June 2012 Abstract As global health authorities align in inspection standards and practices, key
More informationCorso di Laurea Magistrale in Chimica e Tecnologia Farmaceutiche E25
Sezione di Tecnologia e Legislazione Farmaceutiche Maria Edvige Sangalli Corso di Laurea Magistrale in Chimica e Tecnologia Farmaceutiche E25 Fabbricazione Industriale dei Medicinali 4 CFU Supply Chain
More informationOutsource or in-house? The evolving role of analytical services in pharmaceutical manufacturing
Outsource or in-house? The evolving role of analytical services in pharmaceutical manufacturing By Impact Analytical Introduction About Impact Analytical Impact Analytical is a contract analytical testing
More informationQ&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document
Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document March 2017 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 1 ICH Q7 - Questions
More informationWork plan for the GMP/GDP Inspectors Working Group for 2018
30 November 2017 EMA/INS/GMP/504401/2017 Inspections, Human Medicines Pharmacovigilance & Committees Division Work plan for the GMP/GDP Inspectors Working Group for 2018 Chairperson: Brendan Cuddy Adopted:
More informationMarch Harmonization of Standards for Better Regulatory Compliance
March 2010 Harmonization of Standards for Better Regulatory Compliance Contents Abstract 2 High Level Interpretation of USP 3 High Level Interpretation of ASTM E2500 07 4 Aligning ASTM E2500 concepts
More informationIntegrating the Global GDPs into the Quality Management System (QMS) Dave Ulrich
Integrating the Global GDPs into the Quality Management System (QMS) Dave Ulrich Abbvie QA Director Global Supply Chain Agenda: GDP, QMS and QRM 1. What do the regulations say What are the GDPs? Do we
More informationRegulatory Requirements & Recent Changes, including expectations for APIs & IMPs
Regulatory Requirements & Recent Changes, including expectations for APIs & IMPs Neil Raw - GMP Inspector Richard Andrews - Operations Manager 11 th November 2008 Programme: Regulatory Requirements Neil
More informationGUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 047-1 Annex 1 July 2018 GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL
More informationThe importance of healthcare within a an all cargo carrier S. Evangelakakis Global Product Manager Healthcare and Perishables.
The importance of healthcare within a an all cargo carrier S. Evangelakakis Global Product Manager Healthcare and Perishables Victor Laszlo 1 Agenda 1. Who is Cargolux 2. Challenges 3. Lessons learned
More informationCEIV Pharma Webinar Thursday 14 May 2015
CEIV Pharma Webinar Thursday 14 May 2015 Introduction Andrew Lyall Marketing & Business Development, Manager, Air Service Cargo Sales Halifax International Aviation Authority ACI NA Brandon Fried Executive
More informationGDP for APIs New Regulations. we prove it. The Shift to Monitoring BioPharma Product Quality Throughout Their Lifecycle
1 - Temperature Control Challenges - Full Lifecycle Monitoring WHITE PAPER GDP for APIs New Regulations The Shift to Monitoring BioPharma Product Quality Throughout Their Lifecycle we prove it. 2 GDP for
More informationWorking Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice
Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working
More informationThe APIC Audit Programme Version 5, July 2017
The APIC Audit Programme Version 5, July 2017 Table of contents 1 General 2. APIC Audit Programme 3 The Auditors 3.1 Educational Background and Experience 3.2 Auditor Training Courses for Certification
More informationWork plan for the GMP/GDP Inspectors Working Group for 2017
13 January 2017 EMA/INS/GMP/584202/2016 Work plan for the GMP/GDP Inspectors Working Group for 2017 Chairperson: David Cockburn Adopted: December 2016 1. Meetings scheduled for 2017 Face-to-face meetings
More informationCold-Chain & Logistical Challenges of Cell Therapeutics in Clinical Trials
Cold-Chain & Logistical Challenges of Cell Therapeutics in Clinical Trials Dan O Donnell Associate Director, Cell Therapy Logistics Fisher BioServices Part of Thermo Fisher Scientific Logistics of Biologics
More informationQuality Assessment & GMP Similarities & Differences
Quality Assessment & GMP Similarities & Differences EMEA, Monday 26 th October 2009 Cormac Dalton Inspector Irish Medicines Board Date 12-Oct-09 Slide 1 Content Overview of commonalities & differences
More informationReducing Risk and Costs in the Global Supply Chain
Reducing Risk and Costs in the Global Supply Chain Global Quality & Compliance Services for the Life Sciences Industry sensitech.com @sensitech Protecting the Life Sciences Supply Chain Can Be Costly Maintaining
More informationEU Update on Regulatory Developments
EU Update on Regulatory Developments Pascal Venneugues European Medicines Agency CASSS CMC Strategy Forum Europe Copenhagen, 4-6 May 2015 An agency of the European Union Overview International cooperation
More informationUNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products
UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September
More informationPhase Appropriate GMPs for IMPs. Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017
Phase Appropriate GMPs for IMPs Presented by: Karen S. Ginsbury For: IFF, October 31, Nov 02, 2017 1 Lets start with References https://mhrainspectorate.blog.gov.uk/2016/0 5/20/manufacture-of-investigationalmedicinal-products-frequently-askedquestions/
More informationSubmission of comments on 'Commission Guidelines on Good Distribution Practice of Medicinal Products for Human Use'
Date of submission 23 rd December 2011 Submission of comments on 'Commission Guidelines on Good Distribution Practice of Medicinal Products for Human Use' (SANCO/C8/AMan D(2010) 380358) Comments from:
More informationKINGSMANN CARE GROUP
PHARMA CONSULTANTS KINGSMANN CARE GROUP KINGSMANN CONSULTANCY SERVICES Thank you for taking interest in Kingsmann Consultancy Services. Kingsmann Consultancy (KC) is a leading business development-consulting
More informationMHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents
MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Deficiencies in GDP Phil Neale, GDP Operations Manager Tony Orme, GDP Senior Inspector. Finding deficiencies in GDP is not only for those
More informationCompounding Pharmacies and the Contract Testing Lab
Compounding Pharmacies and the Contract Testing Lab Scott Sutton, Ph.D. scott.sutton@microbiol.org 1 Disclaimer I am making this presentation as an independent agent I am not making this presentation as
More informationQuality Systems and GMPin Pharmaceutical Manufacturing. Marleine Akl Quality Assurance Algorithm SAL
Session s Outline 1. Bio-equivalence 2. A 30-minute DVD on GMP Break 3. Quality Systems and GMPs in Pharmaceutical Manufacturing 4. Good Distribution Practices 5. Questionnaire (could not go through due
More informationNew GMPs for Active Substances & Excipients. Presented by Eoin Hanley 4 July, 2016
New GMPs for Active Substances & Excipients Presented by Eoin Hanley 4 July, 2016 What we will cover in this session The changing landscape EC Guideline on principles of GDP of active substances Formalised
More informationRegulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0)
Regulatory Overview Annex 11 and Part 11 Sion Wyn Conformity +[44] (0) 1492 642622 sion.wyn@conform-it.com 1 Two Key Regulations Annex 11 21 CFR Part 11 Apply to the regulated company, but often have a
More informationQuality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines
Human Journals Review Article January 2017 Vol.:8, Issue:2 All rights are reserved by Chagi Venkatesh et al. Quality Assurance in Pharmaceutical Biotech Industries as Per Regulatory Guidelines Keywords:
More informationOverview SFLGDP1- HP Develop, implement and maintain a quality system to control the distribution of medicinal products
- HP97 04 Overview What this standard is about This standard is about developing, implementing and maintaining a quality system to control the. You will be responsible for developing the quality system
More informationCurrent Global GMP Status and Trends With Focus on EU & PIC/S JPMA Annual Meeting, Tokyo & Osaka, September 2012 Dr.-Ing.
Current Global GMP Status and Trends With Focus on EU & PIC/S JPMA Annual Meeting, Tokyo & Osaka, September 2012 Dr.-Ing. Stephan Rönninger Pharma Medicines Technical Operations Global Quality & Compliance,
More informationQMS Aspects of the MDR (& IVDR)
QMS Aspects of the MDR (& IVDR) Vicky Medley Global QMS Manager Medical Devices 27 February 2018 Copyright 2018 BSI. All rights reserved This Presentation 1. The clock is ticking! 2. Dates & priorities
More informationSupervision of manufacturers: What is expected of National Competent Authorities?
Supervision of manufacturers: What is expected of National Competent Authorities? Fergus Sweeney, PhD, European Medicines Agency Head, Compliance and Inspections EU 28: Science, Medicines, Health Dubrovnik,
More informationAPI EUROPEAN GMP REQUIREMENTS. Alessio Ferrari
API EUROPEAN GMP REQUIREMENTS Alessio Ferrari SUMMARY GUIDELINES IMPLICATIONS FOR THE INDUSTRY ARTICLE 46 (F) OF DIRECTIVE 2001/83/EC PART I EU GMP Chapter 5 OFFICIAL MEASURES TO PROTECT. PROCEDURE TO
More informationDECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW
DECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW 1.0 INTRODUCTION: The purpose of this guidance is to communicate the expectation with regard to the conduct of Product Quality Review. Product Quality
More information<1079> Good Storage and Distribution Practices
Good Storage and Distribution Practices Desmond Hunt, Ph.D. Principal Scientific Liaison September 7, 2017 Mexico City, Mexico Good Distribution Practice Activities Suppliers Procuring, holding,
More informationMOVE WITH CONFIDENCE
MOVE WITH CONFIDENCE The TradeLink brings together more than 25 years of international forwarding and logistics expertise and a team committed to making it easier for our customers to transact business
More informationSummary of Proposed USP General Chapter <1083> Good Distribution Practices Supply Chain Integrity 02/15/2012
Summary of Proposed USP General Chapter Good Distribution Practices Supply Chain Integrity 02/15/2012 This summary was prepared by the Rx-360 Monitoring and Reporting Working Group which tracks
More informationTrinity College Dublin QP Forum 2017 Tuesday 25 th April
Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current
More informationMerging & integrating IT systems
Merging & integrating IT systems Pierre-Yves LETOURNEL European Technology Summit 20-21 June, 2005 Amsterdam GEODIS IT Director for Groupage & Logistics Activities The CIO s dilemma New services New Users
More informationHow does the GDP guidelines impacted DGF on Local and Global level. 25 june 2013
How does the GDP guidelines impacted DGF on Local and Global level. 25 june 2013 Overview Introduction Who is DHL? What is GDP? DGF services Global approach DGF services Belgium 2 Introduction Elledin
More informationControl of veterinary products and vaccines Inspection system, monitoring plan, monitoring of vaccines distribution
Workshop for OIE national Focal Points for Veterinary Products (2 nd cycle) Vienna (Austria), 20-22 November 2012 Control of veterinary products and vaccines Inspection system, monitoring plan, monitoring
More informationIntroduction to Temperature Mapping of Controlled Temperature Storage Areas Temperature Mapping 101. Presented by Grant South 7 February, 2018
Introduction to Temperature Mapping of Controlled Temperature Storage Areas Temperature Mapping 101 Presented by Grant South 7 February, 2018 Welcome Introduction to temperature mapping What and why GMP
More informationPROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D.
Basic GMP Requirement PROCESS VALIDATION ROCHAPON WACHAROTAYANKUN, PH.D. Topic Process validation What and Why? Principle of process validation Manufacturing process validation Aseptic process validation
More informationEUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS
EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guidance on CPD for QUALIFIED PERSONS EIPG Guidance on CPD for QP Continuing Professional Development for Qualified Persons, Technical Directors and other Responsible
More information